You are here

PHCRI Memo - March 20, 2020

To: All PHCRI Investigators

In response to the ongoing COVID-19 situation, PHCRI will follow exactly the same procedures as outlined by UBC for research (subject to the directives implemented by the health authority research institutes for clinical trials and REB approved clinical research). Therefore, as of March 24, 2020, all research activities should be curtailed; faculty, staff, undergraduate and graduate students, post-doctoral fellows and visiting professors should work remotely and avoid entering PHC facilities.

This curtailment will be until April 15, 2020 and due to the changing nature of this pandemic, may be extended. This curtailment is to ensure the health and safety of all research personnel and the community. We ask that all Principal Investigators discuss this curtailment with their research personnel and implement plans accordingly.

Exemptions from this curtailment, such as research involving COVID-19, long-term or ongoing research involving animal models, may be requested to continue. However, physical distancing and laboratory safety must be maintained. Please complete the PHCRI Exemption form, obtain signature from your Centre Director or Department Head and submit to for expedited review and approval by PHCRI.

For clinical trials and REB-approved clinical research please refer to the memo below.

We fully understand the impact that this curtailment will have on your research programs and research personnel. We are grateful for your attention and cooperation to this crucial matter.

As always, if you have any questions or concerns, please do not hesitate to contact me.

Dr. Darryl Knight
President, Providence Health Care
Vice-President, Research & Academic Affairs, Providence Health Care
Associate Dean, Research, Faculty of Medicine, University of British Columbia